Claritin Related Published Studies
Well-designed clinical trials related to Claritin (Loratadine)
A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma. [2009.06]
Single-dose desloratadine and montelukast and allergen-induced late airway responses. [2009.06]
Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit. [2009.05]
Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion. [2009.05]
Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit. [2009.04]
How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. [2009.04]
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. [2009.04]
Prevention of recurrent wheezing in young children by loratadine compared with ketotifen. [2009.03]
Effect of desloratadine on patients with allergic rhinitis and exercise-induced bronchoconstriction: a placebo controlled study. [2009.03]
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. [2009.03]
Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients. [2009.01]
Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis. [2009]
Efficacy of montelukast and loratadine as treatment for allergic rhinitis in children. [2008.06]
Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria. [2008.04]
Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. [2008.03]
Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. [2008.02]
Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study. [2008.01]
Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. [2008]
Simultaneous determination of desloratadine and its active metabolite 3-hydroxydesloratadine in human plasma by LC/MS/MS and its application to pharmacokinetics and bioequivalence. [2007.11.30]
Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. [2007.11]
Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults. [2007.08]
The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis. [2007.06]
Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. [2007.05]
An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis. [2007.04]
Effects of desloratadine and alcohol coadministration on psychomotor performance. [2007.02]
Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare. [2007.01]
Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. [2007]
A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults. [2007]
Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study. [2006.12]
Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial. [2006.11]
Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. [2006.11]
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial] [2006.11]
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial] [2006.11]
A randomized controlled trial of cetirizine plus pseudoephedrine versus loratadine plus pseudoephedrine for perennial allergic rhinitis. [2006.06]
A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. [2006.06]
Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis. [2006.05]
Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis. [2006.04]
Desloratadine therapy for symptoms associated with perennial allergic rhinitis. [2006.03]
Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial. [2006.02]
Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. [2006.01]
Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. [2006.01]
Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. [2006]
Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. [2005.12]
The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: a placebo-controlled randomized study. [2005.11]
Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen. [2005.10]
Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients. [2005.10]
Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis. [2005.09]
Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers. [2005.09]
[Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma] [2005.03]
Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis. [2005.03]
Increased nasal airflow with budesonide compared with desloratadine during the allergy season. [2005.03]
Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects. [2005.03]
Safety of desloratadine syrup in children. [2004.12]
An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride. [2004.11]
Pharmacokinetics/pharmacodynamics of desloratadine and fluoxetine in healthy volunteers. [2004.11]
Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours. [2004.10]
Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. [2004.09]
Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. [2004.09]
Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. [2004.07]
Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours. [2004.06]
A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC). [2004.06]
Desloratadine shows no effect on performance during 6 h at 8,000 ft simulated cabin altitude. [2004.05]
Levocetirizine better protects than desloratadine in a nasal provocation with allergen. [2004.04]
Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis. [2004.04]
Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study. [2004.04]
Improvements in simulated real-world relevant performance for patients with seasonal allergic rhinitis: impact of desloratadine. [2004.04]
Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitis. [2004.03]
Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). [2004.02]
[Assessment of the clinical efficacy and safety of epinastine plus pseudoephedrine vs loratadine plus pseudoephedrine in perennial allergic rhinitis] [2004.01]
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. [2004.01]
A comparative study on the effects of naltrexone and loratadine on uremic pruritus. [2004]
A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis. [2004]
A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis. [2004]
Pharmacokinetics and bioequivalence study of a generic desloratadine tablet formulation in healthy male volunteers. [2004]
Effects of loratadine on red wine-induced symptoms and signs of rhinitis. [2003.12]
A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. [2003.10]
Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. [2003.10]
Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. [2003.10]
Pharmacokinetic properties of single-dose loratadine and ambroxol alone and combined in tablet formulations in healthy men. [2003.08]
Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. [2003.08]
Studies on performance and sleepiness with the H1-antihistamine, desloratadine. [2003.08]
Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial. [2003.07]
Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression. [2003.06]
Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. [2003.06]
Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. [2003.05]
Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. [2003.04]
Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. [2003.04]
Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. [2003.03]
The bronchodilatory effects of loratadine, terbutaline, and both together versus placebo in childhood asthma. [2003]
Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis. [2002.10]
Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. [2002.10]
Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion. [2002.09]
Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine. [2002.09]
Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges. [2002.09]
24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]. [2002.08.05]
The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children. [2002.07]
A comparative study of the side effects between pseudoephedrine in Loratadine plus Pseudoephedrine Sulfate Repetabs Tables and loratadine + pseudoephedrine tablet in treatment of allergic rhinitis in Thai patients. [2002.06]
Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. [2002.06]
Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. [2002.06]
Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. [2002.05]
A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model. [2002.03]
|
